These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 26837160)
21. Multidrug-resistant bacteria in hospitalized children: a 5-year multicenter study. Raymond J; Nordmann P; Doit C; Vu Thien H; Guibert M; Ferroni A; Aujard Y Pediatrics; 2007 Apr; 119(4):e798-803. PubMed ID: 17403822 [TBL] [Abstract][Full Text] [Related]
22. Antibiotic Restriction Might Facilitate the Emergence of Multi-drug Resistance. Obolski U; Stein GY; Hadany L PLoS Comput Biol; 2015 Jun; 11(6):e1004340. PubMed ID: 26110266 [TBL] [Abstract][Full Text] [Related]
23. [Antibiotic therapy of intra-abdominal infections in the era of multiresistance]. Eckmann C Chirurg; 2016 Jan; 87(1):26-33. PubMed ID: 26577434 [TBL] [Abstract][Full Text] [Related]
24. A retrospective study on the effects of colistin therapy in children with multidrug-resistant Gram-negative bacterial pathogens: impact of HIV status on outcome. Dimitriades K; Morrow BM; Jeena P Arch Dis Child; 2014 Mar; 99(3):262-6. PubMed ID: 24170687 [TBL] [Abstract][Full Text] [Related]
25. [Multiresistant Bacteria - Antibiotic Prescription and Antibiotics of Last Resort]. Kern WV Dtsch Med Wochenschr; 2018 May; 143(9):643-650. PubMed ID: 29684931 [TBL] [Abstract][Full Text] [Related]
31. Multidrug-resistant Acinetobacter: a threat to the antibiotic era. Peleg AY; Paterson DL Intern Med J; 2006 Aug; 36(8):479-82. PubMed ID: 16866649 [No Abstract] [Full Text] [Related]
32. A review of multidrug resistant surgical site infections. Weese JS Vet Comp Orthop Traumatol; 2008; 21(1):1-7. PubMed ID: 18288338 [TBL] [Abstract][Full Text] [Related]
33. Development of novel antibacterial drugs to combat multiple resistant organisms. Bassetti M; Righi E Langenbecks Arch Surg; 2015 Feb; 400(2):153-65. PubMed ID: 25667169 [TBL] [Abstract][Full Text] [Related]
34. Antibiotic-Resistant Infections and Treatment Challenges in the Immunocompromised Host: An Update. Dumford D; Skalweit MJ Infect Dis Clin North Am; 2020 Dec; 34(4):821-847. PubMed ID: 33131573 [TBL] [Abstract][Full Text] [Related]
35. Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU. Kallel H; Bahloul M; Hergafi L; Akrout M; Ketata W; Chelly H; Hamida CB; Rekik N; Hammami A; Bouaziz M Int J Antimicrob Agents; 2006 Oct; 28(4):366-9. PubMed ID: 16971093 [TBL] [Abstract][Full Text] [Related]
36. The challenge of multidrug resistance: the treatment of gram-negative rod infections. Levin AS; Oliveira MS Shock; 2008 Oct; 30 Suppl 1():30-3. PubMed ID: 18704012 [TBL] [Abstract][Full Text] [Related]
38. The Role of Antibiotic Stewardship and Telemedicine in the Management of Multidrug-Resistant Infections. File TM; Jump RLP; Goff DA Infect Dis Clin North Am; 2020 Dec; 34(4):903-920. PubMed ID: 33131574 [TBL] [Abstract][Full Text] [Related]
39. Lowering methodological standards for studies of multidrug-resistant bacteria is counterproductive. Paul M; Hussein K Clin Microbiol Infect; 2016 Jun; 22(6):497-8. PubMed ID: 27050667 [No Abstract] [Full Text] [Related]
40. Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections. Bassetti M; Repetto E; Righi E; Boni S; Diverio M; Molinari MP; Mussap M; Artioli S; Ansaldi F; Durando P; Orengo G; Bobbio Pallavicini F; Viscoli C J Antimicrob Chemother; 2008 Feb; 61(2):417-20. PubMed ID: 18174197 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]